SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001079973-16-000870
Filing Date
2016-03-23
Accepted
2016-03-23 16:33:16
Documents
70
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR THE FISCAL YEAR ENDED 12/31/2015 appy_10k-123115.htm 10-K 1290209
2 EXHIBIT 23.1 ex23x1.htm EX-23.1 3381
3 EXHIBIT 31.1 ex31x1.htm EX-31.1 14612
4 EXHIBIT 31.2 ex31x2.htm EX-31.2 12910
5 EXHIBIT 32 ex32.htm EX-32 8773
  Complete submission text file 0001079973-16-000870.txt   4787347

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT appy-20151231.xml EX-101.INS 804359
7 XBRL TAXONOMY EXTENSION SCHEMA appy-20151231.xsd EX-101.SCH 36679
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE appy-20151231_cal.xml EX-101.CAL 56048
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE appy-20151231_def.xml EX-101.DEF 148641
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE appy-20151231_lab.xml EX-101.LAB 335167
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE appy-20151231_pre.xml EX-101.PRE 265773
Mailing Address 1585 S. PERRY STREET CASTLE ROCK CO 80104
Business Address 1585 S. PERRY STREET CASTLE ROCK CO 80104 (303) 794-2000
Venaxis, Inc. (Filer) CIK: 0001167419 (see all company filings)

IRS No.: 841553387 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33675 | Film No.: 161524261
SIC: 2835 In Vitro & In Vivo Diagnostic Substances